111 related articles for article (PubMed ID: 6665348)
21. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
[TBL] [Abstract][Full Text] [Related]
22. Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet's patients.
Tunc SE; Aksu K; Keser G; Oksel F; Doganavsargil E; Pirildar T; Turk T; Terzioglu E; Huseyinov A
Rheumatol Int; 2005 Jun; 25(5):326-31. PubMed ID: 15004723
[TBL] [Abstract][Full Text] [Related]
23. Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease.
Leiba M; Seligsohn U; Sidi Y; Harats D; Sela BA; Griffin JH; Livneh A; Rosenberg N; Gelernter I; Gur H; Ehrenfeld M
Ann Rheum Dis; 2004 Nov; 63(11):1445-9. PubMed ID: 15479893
[TBL] [Abstract][Full Text] [Related]
24. Fibrinolytic activity and d-dimer levels in Behçet's syndrome.
Yurdakul S; Hekim N; Soysal T; Fresko I; Bavunoglu I; Ozbakir F; Tabak F; Melikoglu M; Hamuryudan V; Yazici H
Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S53-8. PubMed ID: 16273765
[TBL] [Abstract][Full Text] [Related]
25. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
[TBL] [Abstract][Full Text] [Related]
26. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
27. [The functioning of the fibrinolytic system in Behçet's syndrome].
Asbeck F; Meyer-Boernecke D; van de Loo J
Verh Dtsch Ges Inn Med; 1978; (84):1359-62. PubMed ID: 741967
[No Abstract] [Full Text] [Related]
28. The Effect of Colchicine on Mean Platelet Volume in Behcet's Disease.
Ataş H; Cemil BC; Canpolat F; Gönül M
Ann Clin Lab Sci; 2015; 45(5):545-9. PubMed ID: 26586706
[TBL] [Abstract][Full Text] [Related]
29. Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
Ozatli D; Sayinalp N; Büyükaşik Y; Karakuş S; Haznedaroglu IC; Kirazli S; Ozcebe O; Dündar SV
Rheumatol Int; 2002 Jan; 21(4):137-40. PubMed ID: 11843168
[TBL] [Abstract][Full Text] [Related]
30. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
31. Hemostatic parameters in Behçet's disease: a reappraisal.
Koşar A; Oztürk M; Haznedaroğlu IC; Karaaslan Y
Rheumatol Int; 2002 May; 22(1):9-15. PubMed ID: 12120913
[TBL] [Abstract][Full Text] [Related]
32. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
[TBL] [Abstract][Full Text] [Related]
33. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
Atıl A; Deniz A
Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
[TBL] [Abstract][Full Text] [Related]
34. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
Conard J; Veuillet-Duval A; Horellou MH; Samama M
Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
[TBL] [Abstract][Full Text] [Related]
35. Frosted branch angiitis and cerebral venous sinus thrombosis as an initial onset of neuro-Behçet's disease: a case report and review of the literature.
Ferreira BFA; Rodriguez EEC; Prado LLD; Gonçalves CR; Hirata CE; Yamamoto JH
J Med Case Rep; 2017 Apr; 11(1):104. PubMed ID: 28410605
[TBL] [Abstract][Full Text] [Related]
36. Decreased prostacyclin sensitivity of platelets in patients with Behçet's syndrome.
Wilson AP; Efthimiou J; Betteridge DJ
Eur J Clin Invest; 1988 Aug; 18(4):410-4. PubMed ID: 2971547
[TBL] [Abstract][Full Text] [Related]
37. Budd-Chiari syndrome: a common complication of Behçet's disease.
Bayraktar Y; Balkanci F; Bayraktar M; Calguneri M
Am J Gastroenterol; 1997 May; 92(5):858-62. PubMed ID: 9149201
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous fibrinolytic potential, tPA dependent, is reduced in Behçet's disease.
Lotti T; Matucci-Cerinic M
Br J Dermatol; 1989 Dec; 121(6):713-6. PubMed ID: 2514783
[TBL] [Abstract][Full Text] [Related]
39. [Studies on fibrinolytic activity in Behçet's disease. 3. An approach by affinity chromatography (author's transl)].
Saito K
Nippon Ganka Gakkai Zasshi; 1973 Sep; 77(9):1443-51. PubMed ID: 4271707
[No Abstract] [Full Text] [Related]
40. Total occlusion of inferior vena cava in a patient with antiphospholipid antibody syndrome associated with behçet's disease.
Mukai Y; Tsutsui H; Todaka K; Mohri M; Hirai N; Arai H; Takeshita A
Jpn Circ J; 2001 Sep; 65(9):837-8. PubMed ID: 11548886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
